US 2016/0095895 A1Published application

HIGHLY CONCENTRATED FORMULATIONS OF SOLUBLE Fc RECEPTORS

AssigneeSuppremol GmbH

InventorsPeter Sondermann, Thomas Pohl

Life of this patent

Estimating the term…

Abstract

The present invention relates to novel formulations of soluble Fc receptors and especially to formulations containing high concentrations of soluble FcγRIIB receptor. The invention further relates to the use of such formulations as pharmaceutical compounds for the treatment of autoimmune diseases, infections and other conditions where the immune system is involved.

Claims15

Dependent claims

Formulation containing a soluble Fc receptor (sFcR) in an aqueous buffered solution, wherein the concentration of the Fc receptor is greater than 50 mg/ml and wherein it contains a physiologically acceptable buffer substance.

Dependencies are inferred from the claim text.

Facts

Application: 14/787,097Filed 16 Apr 2014
Priority: EP 13002211.426 Apr 2013
Published: 7 Apr 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification29 codes

A61K 38/00
Medicinal preparations containing peptides
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/19
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles: lyophilised , i.e.…
A61K 38/1774
Receptors; Cell surface antigens; Cell surface determinants: immunoglobulin superfamily

Family

US 10,226,504 B2Related patent
US 2016/0095895 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results